Why Polyketide Therapeutics?

There are thousands of known polyketides, representing a huge and largely untapped drug discovery resource. Polyketides are excellent drug leads, being naturally human biology-rich and drug-like, but they are overlooked in drug discovery because, for others, they are difficult to optimise.  

Unlocking the Potential

novoPT™ is Biotica's unique, proprietary polyketide discovery and development system. novoPT™ makes Biotica the only company able to unlock the therapeutic and commercial potential inherent in the thousands of unexploited polyketides. 

Biotica's R&D Pipeline

Using novoPT™, Biotica has generated proprietary polyketide therapeutics offering innovative approaches to conditions such as asthma, hepatitis C and inflammatory/immune disorders. The quality of these projects has attracted top tier development and commercialisation partners including Pfizer and GSK.